EHC18 Uses, Dosage, Side Effects and more
EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.
| Trade Name | EHC18 |
| Generic | EHC18 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in hepatitis (viral, C) and hepatocellular carcinoma.
How EHC18 works
EHC18 is an oral compound thought to modulate immune responses to HCV by inducing tolerance, or non-responsiveness to viral antigens, thus potentially reducing inflammation.
